https://nature.com/articles/s42003-024-06130-8 The ongoing evolution of SARS-CoV-2 to evade vaccines and therapeutics underlines the need...

https://www.pnas.org/doi/10.1073/pnas.2314166121 The nonstructural protein 1 (Nsp1) of SARS-CoV-2 (Severe Acute Respiratory Syndrome...

https://pubmed.ncbi.nlm.nih.gov/36558898/ Antiviral agents are needed for the treatment of SARS-CoV-2 infections and to control other...

https://pubmed.ncbi.nlm.nih.gov/37235475/ 3CLpro protease from SARS-CoV-2 is a primary target for COVID-19 antiviral drug development....

https://pubmed.ncbi.nlm.nih.gov/36353143/ Considering the significant impact of the recent COVID-19 outbreak, development of...

https://pubmed.ncbi.nlm.nih.gov/37769654/ The SARS-CoV-2 Omicron BA.1 variant emerged in late 2021 and became the globally dominant...

https://pubmed.ncbi.nlm.nih.gov/37315523/ Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily infects the respiratory...

Identification of In Vitro Inhibitors of Monkeypox Replication - PubMed ( nih.gov ) Monkeypox virus (MPXV) infections in humans have...

https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(24)00218-X Further development of direct-acting antiviral...

https://pubmed.ncbi.nlm.nih.gov/36175661/

https://www.mdpi.com/1424-8247/15/12/1448